Conservative treatment of femoral neuropathy following retroperitoneal hemorrhage: a case report and review of literature

Blood Coagul Fibrinolysis. 2014 Oct;25(7):769-72. doi: 10.1097/MBC.0000000000000110.

Abstract

Anticoagulant drugs are used to reduce the incidence of thromboembolic events in patients at risk. However, minor and major bleeding complications may occur during anticoagulation therapy. Femoral neuropathy secondary to retroperitoneal hematoma is a well known complication of anticoagulant drugs. However, treatment of these patients is still controversial, both conservative and surgical treatments have been advocated. Herein, we report a male patient receiving warfarin for 7 years who developed femoral neuropathy due to retroperitoneal hematoma and was successfully treated with conservative methods. We suggest that conservative treatment and appropriate rehabilitation program should be given to the patients who do not demonstrate any signs of a continued bleeding and any progressive neurological deficits.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Femoral Neuropathy / etiology
  • Femoral Neuropathy / therapy*
  • Hematoma / chemically induced
  • Hematoma / complications*
  • Humans
  • Male
  • Retroperitoneal Space / blood supply
  • Risk Factors
  • Thromboembolism / drug therapy*
  • Treatment Outcome
  • Warfarin / adverse effects
  • Warfarin / therapeutic use
  • Young Adult

Substances

  • Anticoagulants
  • Warfarin